Tag: Andrew Grieve

August 14, 2019

Zenabis Global Announces Q2 2019 Results

Zenabis Global (TSX:ZENA) released its financial results for the second quarter that ended on June 30, 2019. As quoted in the press release:...
July 29, 2019

Zenabis Increases Licensed Annual Cultivation Capacity

Zenabis Global (TSX:ZENA) announced Monday (July 29) the licensing of Phase 2C – Part 1 at their facility in Atholville, New...
July 22, 2019

Zenabis Arranges C$10 Million Non-Dilutive Financing via Supply Agreement with Starseed

Zenabis Global (TSX:ZENA) announced today that it has entered into an agreement with Starseed Medicinal who will advance C$10 million to...
July 11, 2019

Zenabis Closes $30 Million Non-Dilutive Financing via Agreement with Tilray

Zenabis Global’s (TSX:ZENA) subsidiary, Zenabis Ltd., has closed its non-dilutive financing via a pre-paid supply agreement with High Park Holdings, a wholly-owned...
July 2, 2019

Zenabis Inks Supply Deal with Tilray

Zenabis Global announced an agreement with Tilray subsidiary High Park Holdings for a dried cannabis supply worth an advance of C$30 million.
June 3, 2019

Zenabis Shares Production License Update

Zenabis Global announced it obtained an industrial hemp production license from Health Canada.
May 13, 2019

Zenabis Increases Licensed Capacity in New Brunswick

Zenabis Global announced and amendment to the licensing at its Atholville, New Brunswick facility for an additional 3,200 kilograms of cannabis...